Healthy Investments Posts Profit From Investment Sales Despite Zero Revenue
The investment company reported a quarterly profit of ₹0.05 crore, a sequential improvement, even as its revenue from operations fell to zero.
Healthy Investments reported a net profit of ₹0.05 crore for Q1 FY27, up 25% from the previous quarter. The profit came entirely from the sale of investments, as the company posted zero revenue from operations.
For an investment company, quarterly earnings are a snapshot of portfolio decisions. Healthy Investments’ first quarter of FY27 shows a business running entirely on asset sales, with no operating revenue to speak of. The company turned a small profit, but the path reveals a firm in a holding pattern, awaiting its next strategic move.
The numbers tell a stark story. Revenue from operations was zero, a 100% drop from the ₹0.10 crore reported in the prior quarter. Yet, net profit for the quarter ended June 2026 was ₹0.05 crore, a 25% sequential increase. This profit, as reported by The Annexure, came from a ₹0.24 crore gain on the sale of investments.
| Period | Revenue (₹ Cr) | Net Profit (₹ Cr) |
|---|---|---|
| Q1 FY27 (Jun 2026) | 0.00 | 0.05 |
| Q4 FY26 (Mar 2026) | 0.10 | 0.04 |
| Q3 FY26 (Dec 2025) | 0.09 | -0.04 |
| Q2 FY26 (Sep 2025) | 0.05 | 0.91 |
| Q1 FY26 (Jun 2025) | 0.00 | -0.86 |
A Business in Transition
The complete absence of operating revenue underscores the company's current state. Its business model, as described in its own snapshot, relies on dividends and dealing in investments. With no dividend income recorded, the quarter's result was solely powered by divesting part of its portfolio. This is not a sustainable engine for growth.
Management appears focused on a boardroom refresh rather than immediate financial engineering. ScanX.Trade reported that the company recently appointed new non-executive and independent directors, including Mr. Ashwin Nandan Singh. This governance strengthening suggests preparations for exploring new business avenues, a stated goal from the company's own filings.
The Valuation Conundrum
The extreme discount in the market is impossible to ignore. Healthy Investments trades at a price-to-earnings ratio of 0.1, a 99.6% discount to its industry, according to the verified data. This reflects a market view that treats the company's sporadic investment gains as non-recurring, not a reliable earnings stream. The micro-cap status and negligible institutional interest further compound this disconnect.
Live Chart
· HEALINV
(BSE)
ISIN: INE160N01017
Key Points
- Healthy Investments reported a Q1 FY27 net profit of ₹0.05 crore, up 25% quarter-on-quarter, despite posting zero revenue from operations.
- The entire profit was generated from a one-off gain on the sale of investments, highlighting the lack of a recurring revenue stream.
- The company is strengthening its board with new appointments, signaling a focus on governance as it seeks new business avenues for future growth.
- The stock trades at a deep valuation discount, with a P/E of 0.1, as the market discounts its earnings as non-recurring.
Hexa Perspective
The quarter confirms Healthy Investments is an asset portfolio in search of an operating business. Profitability is entirely event-driven, reliant on the timing of investment disposals rather than a core income-generating model. The board refresh is a necessary, but early, step toward changing that narrative.
The crucial question is what comes after the portfolio sales. Until the company articulates and executes a clear plan for a sustainable revenue stream, its financial results will remain volatile and its valuation will likely stay disconnected from any traditional metrics. Investors are effectively betting on the board's ability to pivot, not on the current financials.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.